11.05.2016
- Pfizer has entered into an agreement with Wave Life Sciences to develop and commercialize nucleic acid therapies for metabolic diseases. The collaboration, potentially worth more...
11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
09.05.2016
- Sanofi is turning up the heat on its acquisition target, US biopharmaceuticals producer Medivation, but the strategy doesn’t seem to be working. Last week, the French drugmaker...
14.04.2016
- With immediate effect, Merck KGaA has appointed Maya Martinez-Davis (46) as global head of oncology for its biopharma business, succeeding Andrew Schiermeier. She will be based in...
07.04.2016
- The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
06.04.2016
- What a difference a day makes. On Apr. 3, European time, Pfizer and Allergan said the US Federal Trade Commission’s deeper probe into their potential merger, the so-called second...
05.04.2016
- The US Federal Trade Commission (FTC) has asked Pfizer and Allergan for more information in relation with its antitrust review of their proposed merger. The so-called second...
05.04.2016
- Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...
